Francesco Bellinato (F Bellinato)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 64

Top Topics

Systematic Review

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

American journal of clinical dermatology

International journal of molecular sciences

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Zanrè, Francesco Bellinato, Alessia Cardile, Carlotta Passarini, Jacopo Monticelli, Stefano di Bella, Marta Menegazzi
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines. International journal of molecular sciences 25 (3) (2024)
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, Carlotta Passarini, Jacopo Monticelli, Stefano di Bella, Marta Menegazzi
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines. International journal of molecular sciences 25 (3) (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology (2024)
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, Carlotta Passarini, Jacopo Monticelli, Stefano di Bella, Marta Menegazzi
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines. International journal of molecular sciences 25 (3) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, Carlotta Passarini, Jacopo Monticelli, Stefano di Bella, Marta Menegazzi
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines. International journal of molecular sciences 25 (3) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Bianca Maria Piraccini, Francesca Pampaloni, Stephano Cedirian, F Quadrelli, Francesca Bruni, Luca Rapparini, Gemma Caro, M C Acri, L Ala, Alfredo Rossi, G Pellacani, Francesco Lacarrubba, G Micali, F Dall'Oglio, Marina Vastarella, M Cantelli, P Nappa, Laura Diluvio, L Bianchi, Laura Gnesotto, Andrea Sechi, L Naldi, F Tassone, K Peris, Giacomo Caldarola, L M Pinto, Giampiero Girolomoni, F Marangoni, Francesco Bellinato, Paolo Gisondi, I Scandagli, Francesca Prignano, N Pimpinelli, C Tomasini, Stefania Barruscotti, Edoardo De Simoni, O Simonetti, F Ambrogio, C Foti, V Boccaletti, A Fraghì, Angelo Valerio Marzano, M A Mattioli, L Rocca, M Barbareschi, S M Ferrucci, Giuseppe Gallo, Simone Ribero, Pietro Quaglino, R Balestri, T Ioris, R D Caposiena Caro, I Zalaudek, E Vagnozzi, Maria-Concetta Fargnoli, C Caponio, P Rubegni, Elisa Cinotti, Emanuele Trovato, M Romanelli, Valentina Dini, Flavia Manzo Margiotta, Claudio Feliciani, M B de Felici Del Giudice, Laura Atzori, S Sanna, S Lembo, Annunziata Raimondo, Michela Magnano, Michela Valeria Rita Starace
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, Carlotta Passarini, Jacopo Monticelli, Stefano di Bella, Marta Menegazzi
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines. International journal of molecular sciences 25 (3) (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher, Giampiero Girolomoni
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis. Journal of clinical medicine 12 (18) (2023)
Francesco Bellinato, Paolo Gisondi, Annunziata Dattola, A G Richetta, Antonio Costanzo, Mario Valenti, Clara De Simone, Angelo Valerio Marzano, M Zussino, Elena Pezzolo, M Nacca, Giovanni Pellacani, Giampiero Girolomoni
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Andrea Carugno, Michele Parietti, Giulia Ciccarese, Campanati Anna, Diotallevi Federico, Laura Atzori, R Balestri, Stefano Caccavale, Francesco Bellinato, S V Benatti, S Venturelli, P Vezzoli, P Sena, M Papini
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Guido Mioso, Elena Mason, Danny Straiotto, Stefano Piaserico, Giampiero Girolomoni
The transition from mild to moderate-to-severe chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Rebecca Favaro, Alessandra Formai, Giulia Pavia, Luigi Gargiulo, Jessica Avagliano, Mario Valenti, Paola Facheris, Beatrice Salsano, Roberta Valeria Latorre, Francesco Bellinato, Paolo Gisondi, Alessandra Narcisi, Antonio Costanzo
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination. The British journal of dermatology (2023)
Lidia Sacchelli, Federica Filippi, Anna Balato, Riccardo Balestri, Francesco Bellinato, Nicoletta Bernardini, L Bianchi, Martina Burlando, Campanati Anna, Marco Adriano Chessa, M Corazza, Antonella Di Cesare, V Di Lernia, F Diotallevi, Maria Esposito, Maria-Concetta Fargnoli, Paolo Gisondi, Alessandro Giunta, Katharina Hansel, Michela Magnano, Matteo Megna, Giulia Odorici, Francesca Prignano, C Potenza, G Rech, M Rovesti, Ruggiero Angelo, F Satolli, Luca Stingeni, Dino Gibertoni, F Bardazzi
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Guido Mioso, Elena Mason, Danny Straiotto, Stefano Piaserico, Giampiero Girolomoni
The transition from mild to moderate-to-severe chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Anna Balato, Giacomo Caldarola, Edoardo Cammarata, Elena Campione, Andrea Carugno, Andrea Conti, Monica Corazza, Paolo Dapavo, Annunziata Dattola, Vito Di Lernia, Massimo Gasperini, Salvatore Panduri, Francesca Prignano, Francesca Satolli, Enzo Spisni, Giampiero Girolomoni
Awareness of obesity among patients with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Angelo Fassio, Giampiero Girolomoni
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis. Dermatology and therapy (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs 31 (12) (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs (2022)
Paolo Gisondi, Davide Geat, Francesco Bellinato, Giampiero Girolomoni
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis. Expert opinion on biological therapy (2022)
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study. Vaccines 10 (8) (2022)
Paolo Gisondi, Davide Geat, Patrizio Armeni, Francesco Bellinato, Martina Maurelli, Giampiero Girolomoni
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis. Expert opinion on biological therapy (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: Talking points from recent clinical trials. Expert opinion on investigational drugs (2022)
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Monkeypox virus infection: what dermatologist needs to know? Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Paolo Gisondi, Francesco Bellinato
Scurvy as Presenting Sign of Anorexia Nervosa. Journal of cutaneous medicine and surgery 26 (6) (2022)
Paolo Gisondi, Martina Maurelli, Francesco Bellinato, Giampiero Girolomoni
Is risankizumab as needed administration a good option for patients with plaque psoriasis? Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (2) (2022)
Francesco Bellinato, P Gisondi, A Mantovani, G Girolomoni, G Targher
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies. Journal of endocrinological investigation 45 (7) (2022)
Francesco Bellinato, Zeno Fratton, Giampiero Girolomoni, Paolo Gisondi
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 10 (9) (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs 31 (12) (2022)
Francesco Bellinato, Paolo Gisondi, Elena Mason, Paolo Ricci, Martina Maurelli, Giampiero Girolomoni
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis. Dermatology and therapy 12 (6) (2022)
Francesco Bellinato, Maria Gaia Mastrosimini, Giulia Querzoli, Paolo Gisondi, Giampiero Girolomoni
Dupilumab for recalcitrant Kimura disease. Dermatologic therapy 35 (9) (2022)
Martina Maurelli, Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Stefano Piaserico, Andrea Conti, Francesco Messina, Alberto Meneguzzo, Giulia Odorici, Francesco Bellinato, Paolo Gisondi
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (4) (2021)
Francesco Bellinato, Paolo Gisondi, Martina Maurelli, Giampiero Girolomoni
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review. Dermatologic therapy 34 (2) (2021)
Paolo Gisondi, Davide Geat, Francesco Bellinato, Laura Spiazzi, Elisa Danese, Martina Montagnana, Gian Luca Salvagno, Giampiero Girolomoni
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis. Journal of personalized medicine 11 (11) (2021)
Paolo Gisondi, Francesco Bellinato, Giovanni Targher, Luca Idolazzi, Giampiero Girolomoni
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis. Annals of the rheumatic diseases (2021)
Francesco Bellinato, Paolo Rosina, Sokol Sina, Giampiero Girolomoni
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus. Archives of rheumatology 37 (1) (2021)
Paolo Gisondi, Simone Cazzaniga, S Di Leo, Stefano Piaserico, Francesco Bellinato, M Pizzolato, A Gatti, A Eccher, M Brunelli, D Saraggi, Giampiero Girolomoni, L Naldi
Impact of the COVID-19 pandemic on melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Francesco Bellinato, Martina Maurelli, Chiara Colato, Paolo Gisondi, Giampiero Girolomoni
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature. Clinical case reports 9 (6) (2021)
Francesco Bellinato, Isotta Goio, Giovanna Malara, Alessio Rosato, Giovanni Targher, Giampiero Girolomoni, Paolo Gisondi
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis. Journal of cutaneous medicine and surgery 26 (3) (2021)
Francesco Bellinato, Paolo Rosina, Beatrice Tonin, Paolo Gisondi, Giampiero Girolomoni
Predictors of subsequent primary melanoma: a case-control study. Archives of dermatological research (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products. Clinical and experimental dermatology (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. Journal of clinical medicine 10 (22) (2021)
Martina Maurelli, Francesco Bellinato, Giampiero Girolomoni
Adrenergic urticaria successfully treated with omalizumab. The Journal of dermatology 48 (11) (2021)
Paolo Gisondi, Francesco Bellinato, Manfredo Bruni, Giulia De Angelis, Giampiero Girolomoni
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome. Dermatologic therapy 33 (6) (2020)
Paolo Gisondi, Francesco Bellinato, Andrea Chiricozzi, Giampiero Girolomoni
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments. Vaccines 8 (4) (2020)
Paolo Gisondi, Francesco Bellinato, Andrea Conti, P Dapavo, S Piaserico, C De Simone, Andrea Chiricozzi, Annunziata Dattola, P Malagoli, G Malara, A Campanati, M Burlando, Maria Esposito, L Gallo, Giampiero Girolomoni
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis. Expert review of clinical pharmacology 13 (5) (2020)
Andrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies. Vaccines 8 (4) (2020)
Francesco Bellinato, G Girolomoni, Paolo Gisondi
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. The British journal of dermatology 181 (6) (2019)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
A systematic review of treatments for pityriasis lichenoides. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (11) (2019)
Francesco Bellinato, Martina Maurelli, C Colato, R Balter, G Girolomoni, D Schena
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. The British journal of dermatology 180 (4) (2018)